GDEV
Earnings company data as of 4:49 AM ET 10/23
Scheduled
2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 23 Nov | EPS | 1.33 | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 1 Sep | EPS | 1.08 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by GDEV's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $344K sold by 2 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Anton Reingold See RemarksSale$201K 18,209 shares at $11.03 4.7% of stakeTraded Sep 28 Filed Sep 29
-
Marie Juliette France Holive DirectorSale$143K 10,654 shares at $13.45 100% of stakeTraded Jun 3 Filed Jun 3
Also filed in the last 12 months, not counted as buying or selling: 2 option exercises and 1 share withholding for taxes.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K/A | FORM 6-K/A | Filing Doc | |
| 424B3 | Filing Doc | ||
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | Filing Doc | ||
| 20-F | Filing Doc | ||
| SCHEDULE 13D | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 20-F | FORM 20-F | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.